Press "Enter" to skip to content

“Hoppy” Health Benefits – Beer Hops Compounds Could Help Protect Against Alzheimer’s Disease

Hops are a key component of beer’s flavor and aroma. According to new research, compounds extracted from hop flowers can, in lab dishes, inhibit the clumping of amyloid beta proteins, which is associated with Alzheimer’s disease.

Beer is one of the oldest and most popular beverages in the world. Hops, the flowers (or seed cones) of the hop plant Humulus lupulus, make beer bitter and are a key component of beer’s flavor and aroma. The distinct, bitter taste of the hops used to flavor its many varieties of beer is something some people love and others hate.

Now, scientists have discovered that an especially “hoppy” brew might have unique health benefits. According to recent research, chemicals extracted from hop flowers can, in lab dishes, inhibit the clumping of amyloid beta proteins, which is associated with Alzheimer’sAlzheimer's disease is a disease that attacks the brain, causing a decline in mental ability that worsens over time. It is the most common form of dementia and accounts for 60 to 80 percent of dementia cases. There is no current cure for Alzheimer's disease, but there are medications that can help ease the symptoms.” data-gt-translate-attributes=”[{“attribute”:”data-cmtooltip”, “format”:”html”}]”>Alzheimer’s disease (AD). These findings were recently published in ACS Chemical Neuroscience, a scientific journal of the American Chemical Society.

Alzheimer’s disease is a debilitating neurodegenerative disease, often marked by memory loss and personality changes in older adults. Part of the difficulty in treating the disease is the time lag between the start of underlying biochemical processes and the onset of symptoms, with several years separating them. This means that irreversible damage to the nervous system occurs before one even realizes that they may have the disease. Accordingly, preventative strategies and therapeutics that can intervene before symptoms appear are of increasing interest.

Happy Friends Raising Beer Glasses

Although drinking beer may not deliver the Alzheimer’s disease benefits from this discovery, the fact that compounds from hops could serve as the basis for nutraceuticals that combat the development of AD is a reason to celebrate.

One of these strategies involves “nutraceuticals,” or foods that have some type of medicinal or nutritional function. The hop flowers used to flavor beers have been explored as one of these potential nutraceuticals, with previous studies suggesting that the plant could interfere with the accumulation of amyloid beta proteins associated with AD. So, Cristina Airoldi, Alessandro Palmioli, and colleagues wanted to investigate which chemical compounds in hops had this effect.

To identify these compounds, the team of scientists created and characterized extracts of four common varieties of hops using a method similar to that used in the brewing process. In tests, they found that the extracts had antioxidant properties and could prevent amyloid beta proteins from clumping in human nerve cells. The most successful extract was from the Tettnang hop, found in many types of lagers and lighter ales.

When that extract was separated into fractions, the one containing a high level of polyphenols showed the most potent antibiotic and aggregation-inhibiting activity. It also promoted processes that allow the body to clear out misfolded, neurotoxic proteins.

Finally, the research team tested the Tettnang extract in a C. elegans model and found that it protected the worms from AD-related paralysis, though the effect was not very pronounced. The researchers say that although this work may not justify drinking more bitter brews, it shows that hop compounds could serve as the basis for nutraceuticals that combat the development of AD.

Reference: “Alzheimer’s Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity” by Alessandro Palmioli, Valeria Mazzoni, Ada De Luigi, Chiara Bruzzone, Gessica Sala, Laura Colombo, Chiara Bazzini, Chiara Paola Zoia, Mariagiovanna Inserra, Mario Salmona, Ivano De Noni, Carlo Ferrarese, Luisa Diomede and Cristina Airoldi, 25 October 2022, ACS Chemical Neuroscience.
DOI: 10.1021/acschemneuro.2c00444

The authors acknowledge funding from the Italian Ministry of University and Research (MUR).

Source: SciTechDaily